InsiderClue
← All stocks

AN2 Therapeutics, Inc.

ANTX Net buying
CIK 0001880438 #3872 in the set updated 17 Sep 2026
Bought (120 mo)
$51.27M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$19.05M
$542.62K on a plan · $201.33K straight out of an exercise
Sold at will
$18.30M
84 of 103 sales
Net
+$32.23M
+$32.97M against sales at will

By person

18 insiders · 140 transactions
14.3×

Eric Easom holds 14.3 times base salary in stock. $8.64M of shares against $603.75K in salary for 2025.

Salary from the company's own proxy. The shares are what Eric Easom last reported holding, valued at $6.02, the price Common Stock was last bought or sold at on the open market here, on 9 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
RA CAPITAL MANAGEMENT, L.P. entity
10% owner
$41.84M (10)
$3.81M (2)
+$38.04M
300,853
0.7973%
$1.81M
—
Readnour Robin Shane
Director
$2.71M (16)
$428.37K (12) scheduled
+$2.28M
1,267,709
3.36%
$7.64M
+1,559%
Zakrzewski Joseph S
Director
$27.85K (3)
$1.91M (1)
−$1.88M
145,538
0.3857%
$876.76K
−71.2%
Leonard Braden Michael
10% owner
$1.56M (1)
$3.09M (5)
−$1.53M
3,217,432
8.53%
$19.38M
−27.7%
Adjuvant Global Health Technology Fund, L.P. entity
10% owner
$2.50M (1)
$3.98M (20)
−$1.48M
2,373,500
6.29%
$14.30M
—
Aziz Kabeer
Director
$2.50M (1)
$3.98M (20)
−$1.48M
436,648
1.16%
$2.63M
—
Easom Eric
Chief Executive Officer
$114.41K (3)
$1.55M (23)
−$1.44M
1,434,396
3.80%
$8.64M
+30.4%
Krause Kevin Michael
Chief Strategy Officer
—
$201.33K (2) scheduled
−$201.33K
31,914
0.0846%
$192.26K
+1,567%
Eizen Joshua M
See Remarks
—
$65.94K (5)
−$65.94K
206,554
0.5474%
$1.24M
+941.4%
FitzPatrick Margaret M
Director
$21.74K (2)
—
+$21.74K
10,708
0.0284%
$64.51K
—
Chanda Sanjay
Chief Development Officer
—
$13.30K (3)
−$13.30K
118,823
0.3149%
$715.83K
+677.6%
Day Lucy
Chief Financial Officer
—
$12.85K (3)
−$12.85K
118,363
0.3137%
$713.05K
+553.0%
Prior Stephen David
Chief Strategy Officer
—
$10.10K (4)
−$10.10K
59,086
0.1566%
$355.95K
+95.5%
Williams Sarah Joanne
Principal Accounting Officer
—
$3.02K (3)
−$3.02K
66,311
0.1757%
$399.48K
+252.7%
Trenor Cameron C. III
Chief Medical Officer
—
—
—
116,667
0.3092%
$702.84K
—
Marks Gilbert Lynn
Director
—
—
—
81,873
0.2170%
$493.23K
+258.6%
Eckburg Paul
Chief Medical Officer
—
—
—
51,416
0.1363%
$309.75K
+140.1%
Martin Patricia A.
Director
—
—
—
18,863
0.0500%
$113.64K
—

Individual transactions

84
Insider
Date
Role
Action
Shares
Price
Amount
Williams Sarah Joanne
1 Sep 2026
Principal Accounting Officer
Sell
272
$5.53
$1.50K
Eizen Joshua M
8 Jul 2026
See Remarks
Sell
5,945
$4.17
$24.80K
Williams Sarah Joanne
29 May 2026
Principal Accounting Officer
Sell
265
$4.43
$1.17K
Williams Sarah Joanne
3 Mar 2026
Principal Accounting Officer
Sell
327
$1.06
$346.62
Eizen Joshua M
6 Jan 2026
See Remarks
Sell
6,931
$1.01
$7.01K
Chanda Sanjay
6 Jan 2026
Chief Development Officer
Sell
5,956
$1.01
$6.03K
Prior Stephen David
6 Jan 2026
Chief Strategy Officer
Sell
2,858
$1.01
$2.89K
Day Lucy
6 Jan 2026
Chief Financial Officer
Sell
5,512
$1.01
$5.58K
Eizen Joshua M
5 Jan 2026
See Remarks
Sell
17,923
$1.00
$17.95K
Chanda Sanjay
5 Jan 2026
Chief Development Officer
Sell
3,295
$1.00
$3.30K
Prior Stephen David
5 Jan 2026
Chief Strategy Officer
Sell
3,604
$1.00
$3.61K
Day Lucy
5 Jan 2026
Chief Financial Officer
Sell
3,295
$1.00
$3.30K
Prior Stephen David
4 Nov 2025
Chief Strategy Officer
Sell
765
$1.14
$872.10
Eizen Joshua M
4 Nov 2025
See Remarks
Sell
2,819
$1.14
$3.21K
Leonard Braden Michael
30 May 2025
10% owner
Sell indirect
7,000
$1.03
$7.23K
Leonard Braden Michael
30 May 2025
10% owner
Sell indirect
425,000
$1.01
$429.25K
Leonard Braden Michael
28 May 2025
10% owner
Sell indirect
100,000
$1.16
$116.00K
Leonard Braden Michael
28 May 2025
10% owner
Sell indirect
2,000,000
$1.16
$2.32M
Leonard Braden Michael
28 May 2025
10% owner
Sell indirect
200,000
$1.09
$218.00K
Eizen Joshua M
3 Jan 2025
See Remarks
Sell
9,663
$1.34
$12.96K
Prior Stephen David
3 Jan 2025
Chief Strategy Officer
Sell
2,029
$1.34
$2.72K
Chanda Sanjay
3 Jan 2025
Chief Development Officer
Sell
2,957
$1.34
$3.97K
Day Lucy
3 Jan 2025
Chief Financial Officer
Sell
2,957
$1.34
$3.97K
RA CAPITAL MANAGEMENT, L.P.
9 Aug 2024
10% owner
Sell indirect
114,759
$1.08
$123.94K
RA CAPITAL MANAGEMENT, L.P.
9 Aug 2024
10% owner
Sell indirect
3,410,335
$1.08
$3.68M
Zakrzewski Joseph S
18 Jan 2024
Director
Sell indirect
100,000
$19.11
$1.91M
Adjuvant Global Health Technology Fund, L.P.
16 Jan 2024
10% owner
Sell indirect
15,907
$19.65
$312.57K
Adjuvant Global Health Technology Fund, L.P.
16 Jan 2024
10% owner
Sell
84,093
$19.65
$1.65M
Aziz Kabeer
16 Jan 2024
Director
Sell indirect
15,907
$19.65
$312.57K
Aziz Kabeer
16 Jan 2024
Director
Sell indirect
84,093
$19.65
$1.65M
Adjuvant Global Health Technology Fund, L.P.
2 Oct 2023
10% owner
Sell indirect
902
$16.07
$14.50K
Adjuvant Global Health Technology Fund, L.P.
2 Oct 2023
10% owner
Sell
4,770
$16.07
$76.65K
Aziz Kabeer
2 Oct 2023
Director
Sell indirect
902
$16.07
$14.50K
Aziz Kabeer
2 Oct 2023
Director
Sell indirect
4,770
$16.07
$76.65K
Adjuvant Global Health Technology Fund, L.P.
29 Sep 2023
10% owner
Sell indirect
15,764
$16.28
$256.64K
Adjuvant Global Health Technology Fund, L.P.
29 Sep 2023
10% owner
Sell
83,337
$16.28
$1.36M
Aziz Kabeer
29 Sep 2023
Director
Sell indirect
15,764
$16.28
$256.64K
Aziz Kabeer
29 Sep 2023
Director
Sell indirect
83,337
$16.28
$1.36M
Aziz Kabeer
28 Sep 2023
Director
Sell indirect
1,356
$16.11
$21.85K
Aziz Kabeer
28 Sep 2023
Director
Sell indirect
7,160
$16.11
$115.35K
Adjuvant Global Health Technology Fund, L.P.
28 Sep 2023
10% owner
Sell indirect
1,356
$16.11
$21.85K
Adjuvant Global Health Technology Fund, L.P.
28 Sep 2023
10% owner
Sell
7,160
$16.11
$115.35K
Aziz Kabeer
27 Sep 2023
Director
Sell indirect
134
$16.07
$2.15K
Aziz Kabeer
27 Sep 2023
Director
Sell indirect
707
$16.07
$11.36K
Adjuvant Global Health Technology Fund, L.P.
27 Sep 2023
10% owner
Sell indirect
134
$16.07
$2.15K
Adjuvant Global Health Technology Fund, L.P.
27 Sep 2023
10% owner
Sell
707
$16.07
$11.36K
Adjuvant Global Health Technology Fund, L.P.
13 Sep 2023
10% owner
Sell indirect
64
$16.00
$1.02K
Adjuvant Global Health Technology Fund, L.P.
13 Sep 2023
10% owner
Sell
336
$16.00
$5.38K
Aziz Kabeer
13 Sep 2023
Director
Sell indirect
64
$16.00
$1.02K
Aziz Kabeer
13 Sep 2023
Director
Sell indirect
336
$16.00
$5.38K
Aziz Kabeer
7 Sep 2023
Director
Sell indirect
537
$16.05
$8.62K
Aziz Kabeer
7 Sep 2023
Director
Sell indirect
2,841
$16.05
$45.60K
Adjuvant Global Health Technology Fund, L.P.
7 Sep 2023
10% owner
Sell indirect
537
$16.05
$8.62K
Adjuvant Global Health Technology Fund, L.P.
7 Sep 2023
10% owner
Sell
2,841
$16.05
$45.60K
Aziz Kabeer
6 Sep 2023
Director
Sell indirect
598
$16.02
$9.58K
Aziz Kabeer
6 Sep 2023
Director
Sell indirect
3,164
$16.02
$50.69K
Adjuvant Global Health Technology Fund, L.P.
6 Sep 2023
10% owner
Sell indirect
598
$16.02
$9.58K
Adjuvant Global Health Technology Fund, L.P.
6 Sep 2023
10% owner
Sell
3,164
$16.02
$50.69K
Aziz Kabeer
23 Aug 2023
Director
Sell indirect
64
$16.00
$1.02K
Aziz Kabeer
23 Aug 2023
Director
Sell indirect
336
$16.00
$5.38K
Adjuvant Global Health Technology Fund, L.P.
23 Aug 2023
10% owner
Sell indirect
64
$16.00
$1.02K
Adjuvant Global Health Technology Fund, L.P.
23 Aug 2023
10% owner
Sell
336
$16.00
$5.38K
Easom Eric
14 Nov 2022
Chief Executive Officer
Sell
23
$15.04
$345.92
Easom Eric
10 Nov 2022
Chief Executive Officer
Sell
4,413
$15.32
$67.63K
Easom Eric
9 Nov 2022
Chief Executive Officer
Sell
10,111
$15.61
$157.85K
Easom Eric
8 Nov 2022
Chief Executive Officer
Sell
1,255
$16.38
$20.56K
Easom Eric
8 Nov 2022
Chief Executive Officer
Sell
5,800
$15.41
$89.39K
Easom Eric
7 Nov 2022
Chief Executive Officer
Sell
2,036
$16.72
$34.04K
Easom Eric
7 Nov 2022
Chief Executive Officer
Sell
10,167
$15.90
$161.71K
Easom Eric
4 Nov 2022
Chief Executive Officer
Sell
8,828
$15.80
$139.47K
Easom Eric
3 Nov 2022
Chief Executive Officer
Sell
3,083
$16.02
$49.38K
Easom Eric
3 Nov 2022
Chief Executive Officer
Sell
11,082
$15.67
$173.68K
Easom Eric
2 Nov 2022
Chief Executive Officer
Sell
1,544
$15.07
$23.26K
Easom Eric
31 Oct 2022
Chief Executive Officer
Sell
2,688
$15.39
$41.36K
Easom Eric
28 Oct 2022
Chief Executive Officer
Sell
1,683
$15.09
$25.39K
Easom Eric
27 Oct 2022
Chief Executive Officer
Sell
924
$15.36
$14.19K
Easom Eric
26 Oct 2022
Chief Executive Officer
Sell
1,678
$15.10
$25.34K
Easom Eric
25 Oct 2022
Chief Executive Officer
Sell
534
$16.20
$8.65K
Easom Eric
25 Oct 2022
Chief Executive Officer
Sell
4,272
$15.69
$67.02K
Easom Eric
24 Oct 2022
Chief Executive Officer
Sell
2,866
$16.17
$46.34K
Easom Eric
21 Oct 2022
Chief Executive Officer
Sell
2,350
$16.69
$39.23K
Easom Eric
21 Oct 2022
Chief Executive Officer
Sell
11,601
$16.29
$189.01K
Easom Eric
20 Oct 2022
Chief Executive Officer
Sell
31
$17.15
$531.50
Easom Eric
20 Oct 2022
Chief Executive Officer
Sell
7,262
$16.68
$121.14K
Show all 140 transactions →

What was left out

Form 4 filings counted 183
Amendments (4/A) skipped 7
Filings about a different issuer 0
Unreadable filings 0
Joint filings 16
Sales on a Rule 10b5-1 plan 17
Sales straight out of an exercise 2
Sales at will 84
Transactions with no price 0
Shares from compensation/vesting 9,481,921
Sales filed before the plan box existed 22
History held since 31 Mar 2022